Back to Search
Start Over
Additional file 2: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
- Publication Year :
- 2019
- Publisher :
- figshare, 2019.
-
Abstract
- Supplementary materials. (DOCX 27 kb)
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....97607bb0612b4ec99cb0cb88bf7ed1a0
- Full Text :
- https://doi.org/10.6084/m9.figshare.8105837